This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated PSMB8 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-PSMB8 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~30.4 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Lung (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Cleaved | |
| Caveat | Propeptide processing | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 2 isoform(s) |
The M02188-2 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | U937 cell lysate (catalog M02188-2) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M02188-2; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
PSMB8 has a predicted 30.4 kDa precursor; propeptide cleavage and isoforms may affect migration, but no empirical band size or distinct isoform pattern is supplied.
| Band near 30.4 kDa | consistent with the predicted precursor, pending identity controls |
| Band below 30.4 kDa | could reflect removal of the residues 1–72 propeptide |
| Two bands at different positions | could reflect precursor and mature PSMB8 |
| Several discrete bands | could include isoforms 1 and 2, though their migration is unknown |
| Predicted precursor mass | 30.4 kDa is the UniProt prediction, not a measured band position |
| Propeptide at residues 1–72 | cleavage can produce a smaller mature protein; its apparent size is unknown |
| Isoform 1 | may differ in apparent size from isoform 2; direction and separation are unknown |
| Isoform 2 | may differ in apparent size from isoform 1; direction and separation are unknown |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | PSMB8 may be below detection in the tested lysate | compare with U937 lysate as a positive control and check loading |
| Band higher than expected | the 30.4 kDa precursor may be present when a mature band was expected | compare precursor and mature forms using an appropriate band-identity control |
| Band lower than expected | the residues 1–72 propeptide may have been removed | check antibody recognition of mature PSMB8 and confirm identity |
| Multiple bands | precursor processing or isoforms 1 and 2 may contribute | confirm PSMB8 specificity with depletion and compare band patterns |
| Weak or no signal | PSMB8 may be below the assay detection limit | check loading, antibody performance and a U937 lysate control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Lung | alveolar cells type I | High | Protein (IHC) | HPA → |
| Skin | lymphocytes | High | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Medium | Protein (IHC) | HPA → |
| Appendix | glandular cells | Medium | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Heart muscle | cardiomyocytes | Not detected | Protein (IHC) | HPA → |
| Ovary | follicle cells | Not detected | Protein (IHC) | HPA → |
| Skeletal muscle | myocytes | Not detected | Protein (IHC) | HPA → |
| Caudate | neuronal cells | Low | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for PSMB8, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The listed anti-PSMB8/LMP7 monoclonal antibody, M02188-2, has a Western blot image showing proteasome 20S LMP7 expression in U937 cell lysate. The product lists Human, Mouse, and Rat reactivity; the supplied image documents only the stated sample context.
Which to pick: M02188-2 is the only listed option. Its Western blot image uses U937 cell lysate; check that the listed reactivity and this demonstrated sample context fit your experiment.